mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |